Click here to see a list of our past events.
As data-driven innovation accelerates, healthcare stakeholders still struggle with a central question: How do we quantify the value of the data we hold? Even with unprecedented volumes of clinical and operational data, valuation methods remain fragmented and inconsistent. Providers, entrepreneurs and investors often approach data with very different priorities and expectations. Persistent challenges include gaps between perceived and realizable data value, difficulty comparing heterogeneous datasets, and increasing legal and regulatory constraints.
This session will examine how hospitals, digital health innovators, medtech companies and investors are defining and benchmarking data value in real-world transactions. The panel will also explore recommendations for strong data-sharing agreements and how expectations for rigorous, auditable valuation models are evolving.
RSVP here.
Panelists include:
- Roger Cohen, Partner, Goodwin Procter (Moderator)
- Greg Banker, Partner, Vensana Capital
- Chris David, Founder & Managing Partner, HealthValue Group
- Natasha Hunerlach, Partner, EY/Parthenon
- Stefan Vilsmeier, Founder, President & CEO, Brainlab
*This program is being organized by BioVenture eLab of Weill Cornell Medicine Enterprise Innovation with Wendy Diller, founder of LifeScInnovation and author of “Data is the New Gold: Quantifying Its Value To Medtech Presents Challenges,” published in the October 2025 issue of Medtech Strategist.
Do you have a project in need of funding? Are you interested in learning about engaging with industry partners?
James Bellush, Manager of Scientific Scouting, will be hosting weekly virtual office hours, every Friday from 11 a.m. to 1 p.m. to help Weill Cornell investigators support their ongoing translational research projects through industry sponsored research collaborations and grants.
Please use the link here to schedule your private meeting with James. Questions? Email james.bellush@cornell.edu.
If you were unable to attend the live event on December 9, we invite you to join us for an exclusive Zoom replay of the 2025 Accelerating BioVenture Innovation (ABI ) Final Pitch Competition.
Stay ahead of the paperwork that too often slips through the cracks. Join us for an informative session with Nate Cook, Founder of Klausner Cook PLLC, a Corporate, Real Estate, and Intellectual Property Law Practice, and Tom D’Alessandro, Tax Department Head at Sciarabba Walker & Co., LLP, who will break down the essential filing deadlines, tax requirements and regulatory obligations every startup should have on their radar.
Whether you're unsure about what you might be missing or simply want to confirm you're on the right track, this session clarifies financial and legal responsibilities you may not know about.
Perfect for founders looking to stay compliant, RSVP today!
Join us on January 22 for "Telling Your Scientific Story for Commercialization Impact," a new Lab to Impact workshop designed to help researchers and innovators at Cornell University communicate their innovations beyond the lab.
Dr. Julia Felice, a Cornell University alumna, scientist, communicator, and founder of Felice Information Design, will guide participants through how narrative can strengthen understanding, build trust, and accelerate the path from discovery to real-world impact.
In this session, attendees will learn how to adapt their scientific story for diverse audiences, develop a concise “hook” that conveys value to non-technical decision makers, and leave with a practical checklist to support future communication efforts. Participants will also have the opportunity to sign up for follow-up office hours with Dr. Felice for individualized feedback.
If you’re working on a technology with commercial potential, this workshop will help you bridge the communication chasm and position your innovation for stronger partnerships, funding, and traction.
Register here.
